Pharmaceutical composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5375 (2006.01) A61K 9/08 (2006.01) A61K 9/19 (2006.01) A61K 31/724 (2006.01) A61K 47/20 (2006.01) A61K 47/40 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2486571

The present invention provides a pharmaceutical composition comprising N-(3-chloro-4-morpholin-4-yl)phenyl--N'- hydroxyimidoformamidine and sulfobutyl ether .beta.-cyclodextrin or a salt thereof, wherein sulfobutyl ether .beta.-cyclodextrin increases the solubility of N-(3-chloro-4--morpholin-4-yl)phenyl-N'-hydroxyimidoformamidine and improves the stability over time and over heat and light exposure.

La présente invention concerne une composition médicinale qui contient une N-(3-chloro-4-morpholin-4-yl)phényl-N'-hydroxyimidoformamidine, et soit un sulfobutyle-éther à l'état de ?-cyclodextrine, soit l'un de ces sels. Le sulfobutyle-éther à l'état de ?-cyclodextrine augmente la solubilité de la N-(3-chloro-4-morpholin-4-yl)phényl-N'-hydroxyimidoformamidine. Cette composition médicinale se distingue donc par une amélioration de sa stabilité de longue durée et sa stabilité à l'exposition à la chaleur et à la lumière.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1841246

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.